ID   GSK3B_HUMAN             Reviewed;         433 AA.
AC   P49841-2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 2.
DT   12-OCT-2022, entry version 257.
DE   RecName: Full=Isoform 2 of Glycogen synthase kinase-3 beta;
DE            Short=GSK-3 beta;
DE            EC=2.7.11.26 {ECO:0000269|PubMed:14690523};
DE   AltName: Full=Serine/threonine-protein kinase GSK3B;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:17050006, ECO:0000269|PubMed:22539723, ECO:0000269|PubMed:28992046};
GN   Name=GSK3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND MUTAGENESIS OF SER-9.
RX   PubMed=7980435; DOI=10.1042/bj3030701;
RA   Stambolic V., Woodgett J.R.;
RT   "Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells
RT   via serine 9 phosphorylation.";
RL   Biochem. J. 303:701-704(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Eye, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-28.
RX   PubMed=10486203; DOI=10.1006/geno.1999.5875;
RA   Lau K.F., Miller C.C.J., Anderton B.H., Shaw P.C.;
RT   "Molecular cloning and characterization of the human glycogen synthase
RT   kinase-3beta promoter.";
RL   Genomics 60:121-128(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 185-202.
RX   PubMed=10523816; DOI=10.1038/sj.mp.4000538;
RA   Rhoads A.R., Karkera J.D., Detera-Wadleigh S.D.;
RT   "Radiation hybrid mapping of genes in the lithium-sensitive wnt signaling
RT   pathway.";
RL   Mol. Psychiatry 4:437-442(1999).
RN   [6]
RP   FUNCTION IN PHOSPHORYLATION OF JUN.
RX   PubMed=1846781; DOI=10.1016/0092-8674(91)90241-p;
RA   Boyle W.J., Smeal T., Defize L.H., Angel P., Woodgett J.R., Karin M.,
RA   Hunter T.;
RT   "Activation of protein kinase C decreases phosphorylation of c-Jun at sites
RT   that negatively regulate its DNA-binding activity.";
RL   Cell 64:573-584(1991).
RN   [7]
RP   FUNCTION IN PHOSPHORYLATION OF EIF2BE/EIF2B5.
RX   PubMed=8397507; DOI=10.1042/bj2940625;
RA   Welsh G.I., Proud C.G.;
RT   "Glycogen synthase kinase-3 is rapidly inactivated in response to insulin
RT   and phosphorylates eukaryotic initiation factor eIF-2B.";
RL   Biochem. J. 294:625-629(1993).
RN   [8]
RP   PHOSPHORYLATION AT SER-9.
RX   PubMed=8250835; DOI=10.1042/bj2960015;
RA   Sutherland C., Leighton I.A., Cohen P.;
RT   "Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new
RT   kinase connections in insulin and growth-factor signalling.";
RL   Biochem. J. 296:15-19(1993).
RN   [9]
RP   ACTIVITY REGULATION BY AKT1.
RX   PubMed=8524413; DOI=10.1038/378785a0;
RA   Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A.;
RT   "Inhibition of glycogen synthase kinase-3 by insulin mediated by protein
RT   kinase B.";
RL   Nature 378:785-789(1995).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF NFATC1/NFATC.
RX   PubMed=9072970; DOI=10.1126/science.275.5308.1930;
RA   Beals C.R., Sheridan C.M., Turck C.W., Gardner P., Crabtree G.R.;
RT   "Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3.";
RL   Science 275:1930-1934(1997).
RN   [11]
RP   INTERACTION WITH DNM1L.
RC   TISSUE=Liver;
RX   PubMed=9731200; DOI=10.1006/bbrc.1998.9253;
RA   Hong Y.-R., Chen C.-H., Cheng D.-S., Howng S.-L., Chow C.-C.;
RT   "Human dynamin-like protein interacts with the glycogen synthase kinase
RT   3beta.";
RL   Biochem. Biophys. Res. Commun. 249:697-703(1998).
RN   [12]
RP   INTERACTION WITH MUC1, AND FUNCTION.
RX   PubMed=9819408; DOI=10.1128/mcb.18.12.7216;
RA   Li Y., Bharti A., Chen D., Gong J., Kufe D.;
RT   "Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-
RT   associated antigen and beta-catenin.";
RL   Mol. Cell. Biol. 18:7216-7224(1998).
RN   [13]
RP   CHARACTERIZATION.
RX   PubMed=9736715; DOI=10.1073/pnas.95.19.11211;
RA   Delcommenne M., Tan C., Gray V., Rue L., Woodgett J.R., Dedhar S.;
RT   "Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase
RT   kinase 3 and protein kinase B/AKT by the integrin-linked kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:11211-11216(1998).
RN   [14]
RP   INTERACTION WITH NIN.
RX   PubMed=11004522; DOI=10.1016/s0167-4781(00)00127-5;
RA   Hong Y.-R., Chen C.-H., Chang J.-H., Wang S.-K., Sy W.-D., Chou C.-K.,
RA   Howng S.-L.;
RT   "Cloning and characterization of a novel human ninein protein that
RT   interacts with the glycogen synthase kinase 3beta.";
RL   Biochim. Biophys. Acta 1492:513-516(2000).
RN   [15]
RP   ASSOCIATION WITH DIABETES MELLITUS.
RX   PubMed=10868943; DOI=10.2337/diabetes.49.2.263;
RA   Nikoulina S.E., Ciaraldi T.P., Mudaliar S., Mohideen P., Carter L.,
RA   Henry R.R.;
RT   "Potential role of glycogen synthase kinase-3 in skeletal muscle insulin
RT   resistance of type 2 diabetes.";
RL   Diabetes 49:263-271(2000).
RN   [16]
RP   FUNCTION, AND MUTAGENESIS OF ARG-96 AND LEU-128.
RX   PubMed=11430833; DOI=10.1016/s1097-2765(01)00253-2;
RA   Frame S., Cohen P., Biondi R.M.;
RT   "A common phosphate binding site explains the unique substrate specificity
RT   of GSK3 and its inactivation by phosphorylation.";
RL   Mol. Cell 7:1321-1327(2001).
RN   [17]
RP   PHOSPHORYLATION AT SER-9 BY SGK3, AND INTERACTION WITH SGK3.
RX   PubMed=12054501; DOI=10.1016/s0006-291x(02)00349-2;
RA   Dai F., Yu L., He H., Chen Y., Yu J., Yang Y., Xu Y., Ling W., Zhao S.;
RT   "Human serum and glucocorticoid-inducible kinase-like kinase (SGKL)
RT   phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9
RT   through direct interaction.";
RL   Biochem. Biophys. Res. Commun. 293:1191-1196(2002).
RN   [18]
RP   FUNCTION IN PHOSPHORYLATION OF MAPT/TAU.
RX   PubMed=14690523; DOI=10.1111/j.1471-4159.2004.02155.x;
RA   Cho J.H., Johnson G.V.;
RT   "Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta
RT   (GSK3beta) plays a critical role in regulating tau's ability to bind and
RT   stabilize microtubules.";
RL   J. Neurochem. 88:349-358(2004).
RN   [19]
RP   FUNCTION, INTERACTION WITH SNAI1, AND SUBCELLULAR LOCATION.
RX   PubMed=15448698; DOI=10.1038/ncb1173;
RA   Zhou B.P., Deng J., Xia W., Xu J., Li Y.M., Gunduz M., Hung M.C.;
RT   "Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control
RT   of epithelial-mesenchymal transition.";
RL   Nat. Cell Biol. 6:931-940(2004).
RN   [20]
RP   INTERACTION WITH CABYR.
RX   PubMed=15752768; DOI=10.1016/j.bbrc.2005.02.089;
RA   Hsu H.-C., Lee Y.-L., Cheng T.-S., Howng S.-L., Chang L.-K., Lu P.-J.,
RA   Hong Y.-R.;
RT   "Characterization of two non-testis-specific CABYR variants that bind to
RT   GSK3beta with a proline-rich extensin-like domain.";
RL   Biochem. Biophys. Res. Commun. 329:1108-1117(2005).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH SNAI1.
RX   PubMed=15647282; DOI=10.1074/jbc.m413878200;
RA   Yook J.I., Li X.Y., Ota I., Fearon E.R., Weiss S.J.;
RT   "Wnt-dependent regulation of the E-cadherin repressor snail.";
RL   J. Biol. Chem. 280:11740-11748(2005).
RN   [22]
RP   INTERACTION WITH GSKIP.
RX   PubMed=16981698; DOI=10.1021/bi061147r;
RA   Chou H.-Y., Howng S.-L., Cheng T.-S., Hsiao Y.-L., Lieu A.-S., Loh J.-K.,
RA   Hwang S.-L., Lin C.-C., Hsu C.-M., Wang C., Lee C.-I., Lu P.-J.,
RA   Chou C.-K., Huang C.-Y., Hong Y.-R.;
RT   "GSKIP is homologous to the axin GSK3beta interaction domain and functions
RT   as a negative regulator of GSK3beta.";
RL   Biochemistry 45:11379-11389(2006).
RN   [23]
RP   INTERACTION WITH PRUNE1.
RX   PubMed=16428445; DOI=10.1128/mcb.26.3.898-911.2006;
RA   Kobayashi T., Hino S., Oue N., Asahara T., Zollo M., Yasui W., Kikuchi A.;
RT   "Glycogen synthase kinase 3 and h-prune regulate cell migration by
RT   modulating focal adhesions.";
RL   Mol. Cell. Biol. 26:898-911(2006).
RN   [24]
RP   FUNCTION, AND PHOSPHORYLATION AT SER-9.
RX   PubMed=16484495; DOI=10.1126/science.1121613;
RA   Yin L., Wang J., Klein P.S., Lazar M.A.;
RT   "Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of
RT   the circadian clock.";
RL   Science 311:1002-1005(2006).
RN   [25]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF SER-9 AND 85-LYS-LYS-86.
RX   PubMed=17050006; DOI=10.1016/j.bbamcr.2006.09.015;
RA   Garcia-Alvarez G., Ventura V., Ros O., Aligue R., Gil J., Tauler A.;
RT   "Glycogen synthase kinase-3beta binds to E2F1 and regulates its
RT   transcriptional activity.";
RL   Biochim. Biophys. Acta 1773:375-382(2007).
RN   [26]
RP   INTERACTION WITH AXIN1.
RX   PubMed=17318175; DOI=10.1038/sj.emboj.7601607;
RA   Luo W., Peterson A., Garcia B.A., Coombs G., Kofahl B., Heinrich R.,
RA   Shabanowitz J., Hunt D.F., Yost H.J., Virshup D.M.;
RT   "Protein phosphatase 1 regulates assembly and function of the beta-catenin
RT   degradation complex.";
RL   EMBO J. 26:1511-1521(2007).
RN   [27]
RP   FUNCTION, AND INTERACTION WITH BIRC2; DDX3X AND TNFRSF10B.
RX   PubMed=18846110; DOI=10.1038/cdd.2008.124;
RA   Sun M., Song L., Li Y., Zhou T., Jope R.S.;
RT   "Identification of an antiapoptotic protein complex at death receptors.";
RL   Cell Death Differ. 15:1887-1900(2008).
RN   [28]
RP   FUNCTION IN PHOSPHORYLATION OF SIK1.
RX   PubMed=18348280; DOI=10.1002/jcb.21737;
RA   Hashimoto Y.K., Satoh T., Okamoto M., Takemori H.;
RT   "Importance of autophosphorylation at Ser186 in the A-loop of salt
RT   inducible kinase 1 for its sustained kinase activity.";
RL   J. Cell. Biochem. 104:1724-1739(2008).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-402, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-390, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [31]
RP   INTERACTION WITH MMP2.
RX   PubMed=19493954; DOI=10.1093/cvr/cvp175;
RA   Kandasamy A.D., Schulz R.;
RT   "Glycogen synthase kinase-3beta is activated by matrix metalloproteinase-2
RT   mediated proteolysis in cardiomyoblasts.";
RL   Cardiovasc. Res. 83:698-706(2009).
RN   [32]
RP   FUNCTION, AND INTERACTION WITH CLOCK-ARNTL/BMAL1.
RX   PubMed=19946213; DOI=10.4161/cc.8.24.10273;
RA   Spengler M.L., Kuropatwinski K.K., Schumer M., Antoch M.P.;
RT   "A serine cluster mediates BMAL1-dependent CLOCK phosphorylation and
RT   degradation.";
RL   Cell Cycle 8:4138-4146(2009).
RN   [33]
RP   INTERACTION WITH CTNND2.
RX   PubMed=19706605; DOI=10.1074/jbc.m109.002659;
RA   Oh M., Kim H., Yang I., Park J.H., Cong W.T., Baek M.C., Bareiss S., Ki H.,
RA   Lu Q., No J., Kwon I., Choi J.K., Kim K.;
RT   "GSK-3 phosphorylates delta-catenin and negatively regulates its stability
RT   via ubiquitination/proteosome-mediated proteolysis.";
RL   J. Biol. Chem. 284:28579-28589(2009).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [36]
RP   FUNCTION, AND ALTERNATIVE SPLICING.
RX   PubMed=20067585; DOI=10.1111/j.1471-4159.2010.06581.x;
RA   Castano Z., Gordon-Weeks P.R., Kypta R.M.;
RT   "The neuron-specific isoform of glycogen synthase kinase-3beta is required
RT   for axon growth.";
RL   J. Neurochem. 113:117-130(2010).
RN   [37]
RP   FUNCTION.
RX   PubMed=20932480; DOI=10.1016/j.molcel.2010.09.013;
RA   Heyd F., Lynch K.W.;
RT   "Phosphorylation-dependent regulation of PSF by GSK3 controls CD45
RT   alternative splicing.";
RL   Mol. Cell 40:126-137(2010).
RN   [38]
RP   INTERACTION WITH DAB2IP AND PPP2CA.
RX   PubMed=20080667; DOI=10.1073/pnas.0908133107;
RA   Xie D., Gore C., Liu J., Pong R.C., Mason R., Hao G., Long M., Kabbani W.,
RA   Yu L., Zhang H., Chen H., Sun X., Boothman D.A., Min W., Hsieh J.T.;
RT   "Role of DAB2IP in modulating epithelial-to-mesenchymal transition and
RT   prostate cancer metastasis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:2485-2490(2010).
RN   [39]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-9.
RX   PubMed=20937854; DOI=10.1073/pnas.1000975107;
RA   Zaoui K., Benseddik K., Daou P., Salaun D., Badache A.;
RT   "ErbB2 receptor controls microtubule capture by recruiting ACF7 to the
RT   plasma membrane of migrating cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:18517-18522(2010).
RN   [40]
RP   REVIEW ON FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=11749387; DOI=10.1021/cr000110o;
RA   Ali A., Hoeflich K.P., Woodgett J.R.;
RT   "Glycogen synthase kinase-3: properties, functions, and regulation.";
RL   Chem. Rev. 101:2527-2540(2001).
RN   [41]
RP   REVIEW ON FUNCTION.
RX   PubMed=17478001; DOI=10.1016/j.diabres.2007.01.033;
RA   Lee J., Kim M.S.;
RT   "The role of GSK3 in glucose homeostasis and the development of insulin
RT   resistance.";
RL   Diabetes Res. Clin. Pract. 77:S49-S57(2007).
RN   [42]
RP   REVIEW ON FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=19366350; DOI=10.1111/j.1476-5381.2008.00085.x;
RA   Rayasam G.V., Tulasi V.K., Sodhi R., Davis J.A., Ray A.;
RT   "Glycogen synthase kinase 3: more than a namesake.";
RL   Br. J. Pharmacol. 156:885-898(2009).
RN   [43]
RP   INTERACTION WITH GSKIP, AND COMPLEX FORMATION WITH PRKAR2A AND GSKIP.
RX   PubMed=20007971; DOI=10.1074/jbc.m109.047944;
RA   Hundsrucker C., Skroblin P., Christian F., Zenn H.M., Popara V., Joshi M.,
RA   Eichhorst J., Wiesner B., Herberg F.W., Reif B., Rosenthal W.,
RA   Klussmann E.;
RT   "Glycogen synthase kinase 3beta interaction protein functions as an A-
RT   kinase anchoring protein.";
RL   J. Biol. Chem. 285:5507-5521(2010).
RN   [44]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [45]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [46]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND PHOSPHORYLATION.
RX   PubMed=21029237; DOI=10.1111/j.1750-3639.2010.00437.x;
RA   Bose A., Mouton-Liger F., Paquet C., Mazot P., Vigny M., Gray F., Hugon J.;
RT   "Modulation of tau phosphorylation by the kinase PKR: implications in
RT   Alzheimer's disease.";
RL   Brain Pathol. 21:189-200(2011).
RN   [47]
RP   FUNCTION.
RX   PubMed=22514281; DOI=10.1074/jbc.m111.306373;
RA   Sun L., Lv F., Guo X., Gao G.;
RT   "Glycogen synthase kinase 3? (GSK3?) modulates antiviral activity of zinc-
RT   finger antiviral protein (ZAP).";
RL   J. Biol. Chem. 287:22882-22888(2012).
RN   [48]
RP   CATALYTIC ACTIVITY.
RX   PubMed=22539723; DOI=10.1126/science.1217032;
RA   Lin S.Y., Li T.Y., Liu Q., Zhang C., Li X., Chen Y., Zhang S.M., Lian G.,
RA   Liu Q., Ruan K., Wang Z., Zhang C.S., Chien K.Y., Wu J., Li Q., Han J.,
RA   Lin S.C.;
RT   "GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to
RT   autophagy.";
RL   Science 336:477-481(2012).
RN   [49]
RP   ADP-RIBOSYLATION BY PARP10.
RX   PubMed=23332125; DOI=10.1186/1478-811x-11-5;
RA   Feijs K.L., Kleine H., Braczynski A., Forst A.H., Herzog N., Verheugd P.,
RA   Linzen U., Kremmer E., Luscher B.;
RT   "ARTD10 substrate identification on protein microarrays: regulation of
RT   GSK3beta by mono-ADP-ribosylation.";
RL   Cell Commun. Signal. 11:5-5(2013).
RN   [50]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-390, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [51]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [52]
RP   FUNCTION, INTERACTION WITH NCYM, AND PHOSPHORYLATION AT SER-9.
RX   PubMed=24391509; DOI=10.1371/journal.pgen.1003996;
RA   Suenaga Y., Islam S.M., Alagu J., Kaneko Y., Kato M., Tanaka Y., Kawana H.,
RA   Hossain S., Matsumoto D., Yamamoto M., Shoji W., Itami M., Shibata T.,
RA   Nakamura Y., Ohira M., Haraguchi S., Takatori A., Nakagawara A.;
RT   "NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that
RT   inhibits GSK3beta resulting in the stabilization of MYCN in human
RT   neuroblastomas.";
RL   PLoS Genet. 10:E1003996-E1003996(2014).
RN   [53]
RP   PHOSPHORYLATION AT SER-9 AND TYR-216, INTERACTION WITH JPT1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=25169422; DOI=10.1002/jcb.24956;
RA   Varisli L., Ozturk B.E., Akyuz G.K., Korkmaz K.S.;
RT   "HN1 negatively influences the beta-catenin/E-cadherin interaction, and
RT   contributes to migration in prostate cells.";
RL   J. Cell. Biochem. 116:170-178(2015).
RN   [54]
RP   INTERACTION WITH GSKIP, AND COMPLEX FORMATION WITH PRKAR2B AND GSKIP.
RX   PubMed=25920809; DOI=10.1016/j.bbamcr.2015.04.013;
RA   Loh J.K., Lin C.C., Yang M.C., Chou C.H., Chen W.S., Hong M.C., Cho C.L.,
RA   Hsu C.M., Cheng J.T., Chou A.K., Chang C.H., Tseng C.N., Wang C.H.,
RA   Lieu A.S., Howng S.L., Hong Y.R.;
RT   "GSKIP- and GSK3-mediated anchoring strengthens cAMP/PKA/Drp1 axis
RT   signaling in the regulation of mitochondrial elongation.";
RL   Biochim. Biophys. Acta 1853:1796-1807(2015).
RN   [55]
RP   FUNCTION, AND INTERACTION WITH RICTOR.
RX   PubMed=25897075; DOI=10.1074/jbc.m114.633057;
RA   Koo J., Wu X., Mao Z., Khuri F.R., Sun S.Y.;
RT   "Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-
RT   mediated Ubiquitination and Proteasomal Degradation.";
RL   J. Biol. Chem. 290:14120-14129(2015).
RN   [56]
RP   INTERACTION WITH GSKIP, AND COMPLEX FORMATION WITH PRKAR2A AND GSKIP.
RX   PubMed=27484798; DOI=10.1074/jbc.m116.738047;
RA   Dema A., Schroeter M.F., Perets E., Skroblin P., Moutty M.C., Deak V.A.,
RA   Birchmeier W., Klussmann E.;
RT   "The A-Kinase Anchoring Protein (AKAP) Glycogen Synthase Kinase 3beta
RT   Interaction Protein (GSKIP) Regulates beta-Catenin through Its Interactions
RT   with Both Protein Kinase A (PKA) and GSK3beta.";
RL   J. Biol. Chem. 291:19618-19630(2016).
RN   [57]
RP   INTERACTION WITH AXIN1 AND GID8.
RX   PubMed=28829046; DOI=10.1038/cr.2017.107;
RA   Lu Y., Xie S., Zhang W., Zhang C., Gao C., Sun Q., Cai Y., Xu Z., Xiao M.,
RA   Xu Y., Huang X., Wu X., Liu W., Wang F., Kang Y., Zhou T.;
RT   "Twa1/Gid8 is a beta-catenin nuclear retention factor in Wnt signaling and
RT   colorectal tumorigenesis.";
RL   Cell Res. 27:1422-1440(2017).
RN   [58]
RP   FUNCTION, AND INTERACTION WITH ARNTL.
RX   PubMed=28903391; DOI=10.18632/oncotarget.18973;
RA   Lu Y., Zheng X., Hu W., Bian S., Zhang Z., Tao D., Liu Y., Ma Y.;
RT   "Cancer/testis antigen PIWIL2 suppresses circadian rhythms by regulating
RT   the stability and activity of BMAL1 and CLOCK.";
RL   Oncotarget 8:54913-54924(2017).
RN   [59]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF SER-9.
RX   PubMed=28992046; DOI=10.1093/jmcb/mjx034;
RA   Wang D., Zhao J., Li S., Wei J., Nan L., Mallampalli R.K.,
RA   Weathington N.M., Ma H., Zhao Y.;
RT   "Phosphorylated E2F1 is stabilized by nuclear USP11 to drive Peg10 gene
RT   expression and activate lung epithelial cells.";
RL   J. Mol. Cell Biol. 10:60-73(2018).
RN   [60]
RP   FUNCTION.
RX   PubMed=30704899; DOI=10.1016/j.molcel.2018.12.017;
RA   Cheng X., Ma X., Zhu Q., Song D., Ding X., Li L., Jiang X., Wang X.,
RA   Tian R., Su H., Shen Z., Chen S., Liu T., Gong W., Liu W., Sun Q.;
RT   "Pacer is a mediator of mTORC1 and GSK3-TIP60 signaling in regulation of
RT   autophagosome maturation and lipid metabolism.";
RL   Mol. Cell 73:1-15(2019).
RN   [61]
RP   INTERACTION WITH LMBR1L.
RX   PubMed=31073040; DOI=10.1126/science.aau0812;
RA   Choi J.H., Zhong X., McAlpine W., Liao T.C., Zhang D., Fang B., Russell J.,
RA   Ludwig S., Nair-Gill E., Zhang Z., Wang K.W., Misawa T., Zhan X., Choi M.,
RA   Wang T., Li X., Tang M., Sun Q., Yu L., Murray A.R., Moresco E.M.Y.,
RA   Beutler B.;
RT   "LMBR1L regulates lymphopoiesis through Wnt/beta-catenin signaling.";
RL   Science 364:0-0(2019).
RN   [62]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 35-386.
RX   PubMed=11440715; DOI=10.1016/s0092-8674(01)00374-9;
RA   Dajani R., Fraser E., Roe S.M., Young N., Good V., Dale T.C., Pearl L.H.;
RT   "Crystal structure of glycogen synthase kinase 3 beta: structural basis for
RT   phosphate-primed substrate specificity and autoinhibition.";
RL   Cell 105:721-732(2001).
RN   [63]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 27-393 OF PHOSPHORYLATED GSK3B.
RX   PubMed=11738041; DOI=10.1016/s0969-2126(01)00679-7;
RA   Bax B., Carter P.S., Lewis C., Guy A.R., Bridges A., Tanner R., Pettman G.,
RA   Mannix C., Culbert A.A., Brown M.J.B., Smith D.G., Reith A.D.;
RT   "The structure of phosphorylated GSK-3beta complexed with a peptide,
RT   FRATtide, that inhibits beta-catenin phosphorylation.";
RL   Structure 9:1143-1152(2001).
RN   [64]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 35-384 IN COMPLEX WITH AXIN1,
RP   INTERACTION WITH AXIN1 AND FRAT1, FUNCTION, ACTIVITY REGULATION, AND
RP   PHOSPHORYLATION AT TYR-216.
RX   PubMed=12554650; DOI=10.1093/emboj/cdg068;
RA   Dajani R., Fraser E., Roe S.M., Yeo M., Good V.M., Thompson V., Dale T.C.,
RA   Pearl L.H.;
RT   "Structural basis for recruitment of glycogen synthase kinase 3beta to the
RT   axin-APC scaffold complex.";
RL   EMBO J. 22:494-501(2003).
CC   -!- INTERACTION:
CC       P49841-2; P05067: APP; NbExp=3; IntAct=EBI-15870655, EBI-77613;
CC       P49841-2; P35637: FUS; NbExp=3; IntAct=EBI-15870655, EBI-400434;
CC       P49841-2; P01106: MYC; NbExp=3; IntAct=EBI-15870655, EBI-447544;
CC       P49841-2; Q8BMD2-1: Dzip1; Xeno; NbExp=3; IntAct=EBI-15870655, EBI-16153101;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=GSK-3beta1;
CC         IsoId=P49841-1; Sequence=Displayed;
CC       Name=2; Synonyms=GSK-3beta2, neuron-specific;
CC         IsoId=P49841-2; Sequence=VSP_004790;
CC   -!- MISCELLANEOUS: May play a specific role in axon growth and neurite
CC       outgrowth. Reduced binding to AXIN1, reduced ability to phosphorylate
CC       MAPT/TAU. {ECO:0000269|PubMed:20067585}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS2996.1; -.
DR   RefSeq; NP_002084.2; NM_002093.3.
DR   ProteomicsDB; 56152; -.
DR   Ensembl; ENST00000316626.6; ENSP00000324806.5; ENSG00000082701.17.
DR   Proteomes; UP000005640; Chromosome 3.
PE   1: Evidence at protein level;
SQ   SEQUENCE   433 AA;  48034 MW;  540F853E1603A080 CRC64;
     MSGRPRTTSF AESCKPVQQP SAFGSMKVSR DKDGSKVTTV VATPGQGPDR PQEVSYTDTK
     VIGNGSFGVV YQAKLCDSGE LVAIKKVLQD KRFKNRELQI MRKLDHCNIV RLRYFFYSSG
     EKKDEVYLNL VLDYVPETVY RVARHYSRAK QTLPVIYVKL YMYQLFRSLA YIHSFGICHR
     DIKPQNLLLD PDTAVLKLCD FGSAKQLVRG EPNVSYICSR YYRAPELIFG ATDYTSSIDV
     WSAGCVLAEL LLGQPIFPGD SGVDQLVEII KVLGTPTREQ IREMNPNYTE FKFPQIKAHP
     WTKDSSGTGH FTSGVRVFRP RTPPEAIALC SRLLEYTPTA RLTPLEACAH SFFDELRDPN
     VKLPNGRDTP ALFNFTTQEL SSNPPLATIL IPPHARIQAA ASTPTNATAA SDANTGDRGQ
     TNNAASASAS NST
//
